PPACKII (trifluoroacetate salt) Size:Contact [email protected] for quotation Smiles: CN1[C@@H]2CC(C[C@H]1CC2)OC(=O)[C@H](CO)C1C=CC=CC=1

Smiles: CN1[C@@H]2CC(C[C@H]1CC2)OC(=O)[C@H](CO)C1C=CC=CC=1

8R)-6-hydroxy-5-methyl-13-oxo-5

Smiles: CN1C=C(C=N1)C1=CC(=CC=N1)OC1=CC=C(N=C1C)N1N=C(NC1=O)C(C)(C)C

H292 and A549 cells) significantly decreases the number of cells invading across the matrix and transwell filter within 24 hours in a dose-dependent manner

PPACKII (trifluoroacetate salt) Size:Contact [email protected] for quotation Smiles: CN1[C@@H]2CC(C[C@H]1CC2)OC(=O)[C@H](CO)C1C=CC=CC=1PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins . Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate. Kallikrein has diverse expression patterns and physiological roles. Kallikrein has been primarily known as cancer biomarkers. Kallikrein has been implicated in many cancer related processes, such as cell